T9	Treatment 9 98	high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol
T10	Subject 102 186	increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma
T11	Age 117 125	children
T12	Treat-Disorder 131 159	acute lymphoblastic leukemia
T13	Treat-Disorder 164 186	lymphoblastic lymphoma
T14	Speculation_cue 112 116	risk
T15	Drug 19 29	cytarabine
T16	Dosage 9 18	high-dose
T1	Potential_therapeutic_event 0 5	Value
E1	Potential_therapeutic_event:T1 
